Form 4: Atara Biotherapeutics EVP, CFO Eric J. Hyllengren Sells Shares to Cover Tax Obligations

Eric J. Hyllengren, EVP and CFO of Atara Biotherapeutics, sold shares of common stock to satisfy tax withholding obligations related to vesting restricted stock units.

Summary

• On March 4, 2024, Eric J. Hyllengren, the EVP and CFO of Atara Biotherapeutics, sold shares of the company's common stock.
• The sales were executed in two transactions at a weighted average price of $0.721 and $0.72 per share.
• A total of 1,462 and 5,217 shares were sold in the respective transactions.
• These sales were conducted to cover tax withholding obligations associated with the vesting of previously granted restricted stock units.
• Following the reported transactions, Hyllengren beneficially owns 674,319 shares of Atara Biotherapeutics common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to routine stock sales for tax purposes and doesn't indicate any fundamental change in the company's prospects.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. The impact on the stock price is usually minimal unless the sales are substantial or indicative of a change in the executive's confidence in the company.

Key Dates